Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AbbVie Inc.
Report date February 28, 2017 · Filed March 02, 2017
Section 16 reporting ended · disclosed 2017-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, $0.01 par valueSEC Table I · non-derivative | Direct | 62,329 |
Ending reported balance
After 2017-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2017-02-28 · Sale · Disposed 200 · Balance 69,387 Row 2 · 2017-02-28 · Sale · Disposed 1,911 · Balance 67,476 Row 3 · 2017-02-28 · Sale · Disposed 200 · Balance 67,276 Row 4 · 2017-02-28 · Tax withholding · Disposed 4,947 · Balance 62,329 |
| Common stock, $0.01 par valueSEC Table I · non-derivative | IndirectProfit sharing trust | 447 |
Reported balance
Holding disclosure · report date 2017-02-28 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 447 F1: Balance in the AbbVie Savings Program as of February 28, 2017. |
| Common stock, $0.01 par valueSEC Table I · non-derivative | IndirectBy spouse in IRA | 274 |
Reported balance
Holding disclosure · report date 2017-02-28 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 274 F2: The reporting person disclaims beneficial ownership of all securities held by his spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the AbbVie Savings Program as of February 28, 2017.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2017 Filed Mar 2, 2017 23:12 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 4,947 | $62.22 | $307,802.34 |
DisclosureSEC source: 0001179110-17-003703 · edgar.xml · nonDerivative · entry 4 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,329 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 23:12 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $61.90 | $12,379.00 |
DisclosureSEC source: 0001179110-17-003703 · edgar.xml · nonDerivative · entry 3 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,276 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 23:12 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,911 | $61.89 | $118,273.70 |
DisclosureSEC source: 0001179110-17-003703 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,476 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 23:12 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $61.89 | $12,378.00 |
DisclosureSEC source: 0001179110-17-003703 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,387 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:51 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 13,050 | $0.00 Strike: $61.36 | $0.00 |
DisclosureSEC source: 0001179110-17-002810 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,050 Underlying: Common shares · 13,050 shares Expires 2027-02-15 F5 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 4,350 on 02/16/2018, 4,350 on 02/16/2019, and 4,350 on 02/16/2020. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:51 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 2,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002810 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,587 F2 · shares: Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:51 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 5,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002810 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,061 F1 · shares: Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 22:39 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 3,100 | $0.00 Strike: $28.86 | $0.00 |
DisclosureSEC source: 0001179110-16-031870 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 Underlying: Common stock · 3,100 shares Expires 2018-02-14 Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 22:39 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,100 | $62.00 | $192,200.00 |
DisclosureSEC source: 0001179110-16-031870 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,449 Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 22:39 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 3,100 | $28.86 | $89,474.68 |
DisclosureSEC source: 0001179110-16-031870 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2016 Filed Aug 8, 2016 21:43 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 755 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-028396 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,449 Read SEC document |
| May 10, 2016 Filed May 12, 2016 21:44 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 6,000 | $0.00 Strike: $27.29 | $0.00 |
DisclosureSEC source: 0001179110-16-024456 · edgar.xml · derivative · entry 6 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,000 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2016 Filed May 12, 2016 21:44 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $63.60 | $6,360.00 |
DisclosureSEC source: 0001179110-16-024456 · edgar.xml · nonDerivative · entry 3 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,204 Read SEC document |
| May 10, 2016 Filed May 12, 2016 21:44 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 5,900 | $63.59 | $375,181.00 |
DisclosureSEC source: 0001179110-16-024456 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,304 Read SEC document |
| May 10, 2016 Filed May 12, 2016 21:44 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 6,000 | $27.29 | $163,740.00 |
DisclosureSEC source: 0001179110-16-024456 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:22 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,444 | $55.25 | $79,776.67 |
DisclosureSEC source: 0001179110-16-020679 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,204 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:22 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 4,812 | $56.00 | $269,472.00 |
DisclosureSEC source: 0001179110-16-020679 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,648 Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:08 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 15,110 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019782 · edgar.xml · derivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,110 Underlying: Common shares · 15,110 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 5,037 on 02/18/2017, 5,036 on 02/18/2018, and 5,037 on 02/18/2019. Read SEC document |
| May 19, 2015 Filed May 21, 2015 21:50 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 6,200 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001179110-15-008385 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,200 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2015 Filed May 21, 2015 21:50 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 6,200 | $66.00 | $409,200.00 |
DisclosureSEC source: 0001179110-15-008385 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,460 Read SEC document |
| May 19, 2015 Filed May 21, 2015 21:50 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 6,200 | $22.94 | $142,232.34 |
DisclosureSEC source: 0001179110-15-008385 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2015 Filed Mar 3, 2015 23:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 1,862 | $60.50 | $112,651.00 |
DisclosureSEC source: 0001179110-15-004095 · edgar.xml · nonDerivative · entry 3 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,460 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 23:06 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,185 | $60.57 | $71,776.64 |
DisclosureSEC source: 0001179110-15-004095 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,322 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 23:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 2,524 | $60.52 | $152,752.48 |
DisclosureSEC source: 0001179110-15-004095 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,507 Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 22:10 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 21,390 | $0.00 Strike: $58.88 | $0.00 |
DisclosureSEC source: 0001179110-15-003163 · edgar.xml · derivative · entry 4 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,390 Underlying: Common stock · 21,390 shares Expires 2025-02-18 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 7,130 on 02/19/2016, 7,130 on 02/19/2017, and 7,130 on 02/19/2018. Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 22:10 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 10,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003163 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,031 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| November 24, 2014 Filed Nov 26, 2014 22:00 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $67.82 | $6,781.50 |
DisclosureSEC source: 0001179110-14-017220 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,211 Read SEC document |
| November 24, 2014 Filed Nov 26, 2014 22:00 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,400 | $67.81 | $94,935.54 |
DisclosureSEC source: 0001179110-14-017220 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,311 Read SEC document |
| November 06, 2014 Filed Nov 7, 2014 22:57 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $24.07 | $0.00 |
DisclosureSEC source: 0001179110-14-016292 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 10,000 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2014 Filed Nov 7, 2014 22:57 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 6,737 | $62.54 | $421,331.98 |
DisclosureSEC source: 0001179110-14-016292 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,711 Read SEC document |
| November 06, 2014 Filed Nov 7, 2014 22:57 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 10,000 | $24.07 | $240,731.00 |
DisclosureSEC source: 0001179110-14-016292 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:13 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 3,360 | $50.91 | $171,057.60 |
DisclosureSEC source: 0001179110-14-004335 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,448 Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 21,070 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003477 · edgar.xml · derivative · entry 4 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,070 Underlying: Common stock · 21,070 shares Expires 2024-02-19 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 7,024 on 02/20/2015, 7,023 on 02/20/2016, and 7,023 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 12,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003477 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,808 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:33 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 9,138 | $0.00 Strike: $44.93 | $0.00 |
DisclosureSEC source: 0001179110-14-003084 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 9,138 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:33 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 8,428 | $50.73 | $427,552.44 |
DisclosureSEC source: 0001179110-14-003084 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,588 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:33 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 9,138 | $44.93 | $410,570.34 |
DisclosureSEC source: 0001179110-14-003084 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2013 Filed Nov 21, 2013 22:07 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 2,158 | $0.00 Strike: $24.07 | $0.00 |
DisclosureSEC source: 0001179110-13-016855 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,158 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2013 Filed Nov 21, 2013 22:07 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 1,063 | $48.87 | $51,948.81 |
DisclosureSEC source: 0001179110-13-016855 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,878 Read SEC document |
| November 19, 2013 Filed Nov 21, 2013 22:07 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 2,158 | $24.07 | $51,949.75 |
DisclosureSEC source: 0001179110-13-016855 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 155 | $0.00 Strike: $44.93 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 20 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155 Underlying: Common stock · 155 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 778 | $0.00 Strike: $44.93 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 19 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 778 Underlying: Common stock · 778 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 3,479 | $0.00 Strike: $44.93 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 18 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,479 Underlying: Common stock · 3,479 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 562 | $0.00 Strike: $44.93 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 17 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562 Underlying: Common stock · 562 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 3,006 | $0.00 Strike: $44.93 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 16 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,006 Underlying: Common stock · 3,006 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 1,158 | $0.00 Strike: $44.93 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 15 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Common stock · 1,158 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 191 | $0.00 Strike: $29.40 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 14 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 191 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 978 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 13 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 978 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 4,373 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 12 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 4,373 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 703 | $0.00 Strike: $27.93 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 11 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 703 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.